Last reviewed · How we verify

NCT03477214

Tactile Imaging and Electromyography

Completed Last updated 13 April 2020
What this trial tests

trial testing Biomechanical and electromyography mapping in Urinary Incontinence in 20 participants. Completed in 15 March 2020.

Timeline
24 December 2017
Primary endpoint
10 March 2020
15 March 2020

Quick facts

Lead sponsorAdvanced Tactile Imaging, Inc.
StatusCompleted
Study typeOBSERVATIONAL
Enrollment20
Start date24 December 2017
Primary completion10 March 2020
Estimated completion15 March 2020
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Advanced Tactile Imaging, Inc.

Who can join

21 and older, female only, with Urinary Incontinence or Overactive Bladder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Urinary incontinence (UI) and overactive bladder (OAB) in women has high prevalence which is increasing with the age. In adults aged 40 and older in the US demonstrated prevalence rate of 27.2% among man and 43.1% among women, respectively. Urine Incontinence was reported to affect 15% of women ages 40 to 49, 25% ages 60 to 69, and 38% of women age 80 and older.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Urinary Incontinence

Currently open trials in the same condition.

Other Advanced Tactile Imaging, Inc. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03477214.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing